Teva has re-launched its generic of Ritalin LA (methylphenidate hydrochloride) extended-release capsules. The drug is indicated to treat attention deficit hyperactivity disorder.
“The reintroduction of … is important to Teva’s generic portfolio,” Teva’s COO of North American generics, Maureen Cavanaugh, said. “We continue to be focused on bringing affordable generic treatment options to our customers.”